Polypyrrolinone based inhibitors of matrix metalloproteases
    3.
    发明授权
    Polypyrrolinone based inhibitors of matrix metalloproteases 有权
    基于聚吡咯烷酮的基质金属蛋白酶抑制剂

    公开(公告)号:US06455570B1

    公开(公告)日:2002-09-24

    申请号:US09973493

    申请日:2001-10-09

    IPC分类号: A61K3140

    CPC分类号: C07D207/36

    摘要: A compound of the formula wherein: R1, R2, R3, R4, R5, R6 are as defined herein, useful for the inhibition of inhibition of matrix metalloproteases (MMPs)and for treating conditions mediated by elevated levels of MMPs such as osteoarthritis, rheumatoid arthritis, septic arthritis, periodontal disease, gingivitis, solid tumor growth and tumor invasion by secondary metastasis, corneal ulceration, dermal ulceration, epidermolysis bullosa, neural degeneration, multiple sclerosis and surgical wound healing.

    摘要翻译: 方解石的化合物:R1,R2,R3,R4,R5,R6如本文所定义,可用于抑制基质金属蛋白酶(MMPs)的抑制和用于治疗由升高的MMP水平介导的病症,例如骨关节炎,类风湿性关节炎 脓毒性关节炎,牙周病,牙龈炎,实体肿瘤生长和继发性转移肿瘤侵袭,角膜溃疡,皮肤溃疡,大疱性表皮松解,神经变性,多发性硬化和手术伤口愈合。

    Solution and solid phase synthesis of pyrrolinones and polypyrrolinones
    7.
    发明授权
    Solution and solid phase synthesis of pyrrolinones and polypyrrolinones 有权
    吡咯啉酮和聚吡咯啉酮的溶液和固相合成

    公开(公告)号:US07772159B2

    公开(公告)日:2010-08-10

    申请号:US10894916

    申请日:2004-07-20

    IPC分类号: C40B50/14 C40B50/18

    CPC分类号: C07D207/36

    摘要: The invention provides a new process for the preparation of polypyrrolinones (I) of various sizes which have found to be useful peptidomimetics. One aspect of the invention is a new process utilizing α-amino-α-substituted-valerolactones as synthons. A second aspect of the invention is a process for the synthesis of polypyrrolinones using solid-phase techniques.

    摘要翻译: 本发明提供了一种制备各种尺寸的聚吡咯烷酮(I)的新方法,其已经发现是有用的肽模拟物。 本发明的一个方面是利用α-氨基-α-取代 - 戊内酯作为合成子的新方法。 本发明的第二方面是使用固相技术合成聚吡咯烷酮的方法。